These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24070126)

  • 1. The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations.
    Neyt M; Van Brabandt H; Devos C
    BMC Cardiovasc Disord; 2013 Sep; 13():78. PubMed ID: 24070126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-utility of left ventricular assist devices for end-stage heart failure patients ineligible for cardiac transplantation: a systematic review and critical appraisal of economic evaluations.
    Neyt M; Van den Bruel A; Smit Y; De Jonge N; Vlayen J
    Ann Cardiothorac Surg; 2014 Sep; 3(5):439-49. PubMed ID: 25452904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Catheter ablation of atrial fibrillation: Health Technology Assessment Report from the Italian Association of Arrhythmology and Cardiac Pacing (AIAC)].
    Themistoclakis S; Tritto M; Bertaglia E; Berto P; Bongiorni MG; Catanzariti D; De Fabrizio G; De Ponti R; Grimaldi M; Pandozi C; Tondo C; Gulizia M
    G Ital Cardiol (Rome); 2011 Nov; 12(11):726-76. PubMed ID: 22048448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.
    Khaykin Y; Wang X; Natale A; Wazni OM; Skanes AC; Humphries KH; Kerr CR; Verma A; Morillo CA
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):7-12. PubMed ID: 18803564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
    Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
    J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.
    Chew DS; Loring Z; Anand J; Fudim M; Lowenstern A; Rymer JA; Weimer KED; Atwater BD; DeVore AD; Exner DV; Noseworthy PA; Yancy CW; Mark DB; Piccini JP
    Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007094. PubMed ID: 33280436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation.
    Baykaner T; Duff S; Hasegawa JT; Mafilios MS; Turakhia MP
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):526-536. PubMed ID: 29436112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-benefit analysis of concomitant atrial fibrillation management in Spain].
    López Gude MJ; Rodríguez Bezos D; Rodríguez Barrios JM
    Gac Sanit; 2010; 24(1):59-65. PubMed ID: 19931216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of atrial fibrillation catheter ablation.
    Andrikopoulos G; Tzeis S; Maniadakis N; Mavrakis HE; Vardas PE
    Europace; 2009 Feb; 11(2):147-51. PubMed ID: 19098290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.
    Nyong J; Amit G; Adler AJ; Owolabi OO; Perel P; Prieto-Merino D; Lambiase P; Casas JP; Morillo CA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012088. PubMed ID: 27871122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
    Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
    Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation for atrial fibrillation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation.
    Anderson LH; Black EJ; Civello KC; Martinson MS; Kress DC
    J Med Econ; 2014 Jul; 17(7):481-91. PubMed ID: 24693987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
    Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
    Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.